Raloxifene Tablets
Osteoporosis
60mg
Raloxifene 60mg film-coated tablets, used in the management of osteoporosis. A SERM that acts like oestrogen on bone but not on breast tissue.
From$1.02/ tabletView
Raloxifene
Often recognised by the brand Evista, Raloxifene is a medication primarily used to manage bone density in postmenopausal women. The compound functions as a selective oestrogen receptor modulator.
Key points
- Mimics oestrogen’s protective effect on bone while blocking its action in other tissues, unlike standard hormone therapy.
- Reserved for postmenopausal women, since consistent use aims to preserve bone density and reduce fracture risk over time.
- Because it may affect clotting, caution is advised around surgery or long periods of immobility such as travel.
- Should not be combined with systemic oestrogen therapy, which would work against its intended action.
What is Raloxifene?
Selective oestrogen receptor modulators function as a unique class of active ingredients. These agents selectively modulate oestrogen receptors in different tissues throughout the body, producing oestrogen-like effects on bone while blocking those effects in other areas. Clinical use of the active compound focuses on long-term health management strategies.
What Raloxifene is used for
Medical professionals often recommend this medication to address issues related to Osteoporosis. Because it acts on bone density, usage is typically reserved for women who have gone through menopause.
Due to its action on tissue, consistent use helps maintain the structural integrity of bone tissue, which aims to reduce the risk of fractures over time.
How does Raloxifene work?
Selective oestrogen receptor modulators function by mimicking oestrogen in some tissues and opposing it in others. By binding to oestrogen receptors in bone cells, the medication encourages bone density retention.
Active binding in other bodily systems simultaneously blocks oestrogen effects, which limits systemic side effects often associated with traditional hormone replacement therapies.
Raloxifene brands and forms
Evista serves as the well-known originator brand for this active ingredient. Patients seeking alternatives often look for generic products to manage their needs.
Since the ingredient belongs to specialised classes like Women’s Health and Bone Health, there is limited variation in administration methods. Film-coated tablets remain the most common form available, designed for consistent oral absorption and convenience.
Safety overview for Raloxifene
What to check before using this medicine
Ensure you do not have a history of blood clots or venous thromboembolism before beginning any regimen. Those preparing for long periods of immobility, such as surgery or extended travel, should notify a doctor as this medication may alter clotting risk profiles.
Possible reactions and tolerability
Common responses may include hot flushes, muscle cramps, or swelling in the extremities. While many users tolerate the medication well, individual physiological responses vary significantly. Monitoring for symptoms of deep vein thrombosis is standard practice during treatment.
Interactions and health factors
Do not combine with systemic oestrogen therapy, as these may interfere with the intended mechanism of action. Certain medications involving bile acid sequestrants can reduce absorption. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.